01 — At a Glance
The Marlboro Cash Machine That Nobody Wants Right Now
- 52-Week High / Low₹3,947 / ₹1,666
- TTM Revenue₹6,177 Cr
- TTM PAT₹1,298 Cr
- TTM EPS₹82.3
- Q3 FY26 EPS₹22.01
- Book Value₹374
- Price to Book5.43x
- Dividend Yield1.58%
- Debt / Equity0.03x
- 6-Month Return-42.9%
The Headline: Q3 FY26 nets ₹343 crore (8.2% YoY growth), with EPS at ₹22.01. Annualised EPS = ₹88.04. P/E = 22.7x (recomputed). Domestic cigarette volumes up 25% YoY, unmanufactured tobacco exports contributing ₹1,255 Cr in 9M FY26. But the stock? Down 42.9% in 6 months. Because apparently, doubling profit growth is bad for equity value. Welcome to 2025 equity markets.
02 — Introduction
Godfrey Phillips: The Millennial Company Your Boomer Grandpa Smokes
Godfrey Phillips India is a 90-year-old FMCG legend that makes one product very, very well: cigarettes. Specifically, it manufactures and distributes the Marlboro brand in India under an exclusive deal with Philip Morris International (PMI). The company also exports unmanufactured tobacco, makes some confectionery called Funda Goli, and had a brief retail fantasy with 24Seven convenience stores — which it mercifully exited in 2024 after losing money on every single store.
The business is almost absurdly simple: buy base tobacco from farmers, blend it, roll it into cigarettes under license, and sell it through 950+ distributors and a 9,000-strong field force across India. Market share? ~18% of the Indian cigarette industry. Revenue? ₹6,177 crore TTM. Profit? ₹1,298 crore. Return on capital? 26.3%. The company has a CRISIL AA+/Stable rating, zero net debt, and more cash than it knows what to do with.
And yet the stock is down 43% in 6 months. Not because anything broke. Not because regulations changed. Not because the product suddenly went out of style. But because the market decided that a stable, high-return, cash-generative cigarette business is now valued like a failing retailer. This is the story of Q3 FY26 — where fundamentals got better, but sentiment imploded.
Management Quote (Jan 2026 Concall): “We remain committed to delivering long-term value to our stakeholders.” Translation: We’re printing money. Please buy the stock. Anyone?
03 — Business Model: Marlboro or Bust
One Brand. One Market. Infinite Consistency.
Godfrey Phillips is 99% tobacco and 1% everything else. Within tobacco: ~75% is Marlboro (distributed under exclusive PMI deal), and ~25% is own-brand cigarettes and unmanufactured tobacco exports. Non-tobacco? Funda Goli candies and Ferrero product distribution. The retail 24Seven business got shuttered because it was bleeding cash on every transaction — a rare moment of management clarity.
Domestic cigarette segment delivers steady volume growth. Q3 FY26 domestic volumes: 1,985 million sticks/month, up 25% YoY from 1,590M. The company holds ~18% of the Indian cigarette market — second only to ITC’s ~70% stranglehold. Unmanufactured tobacco exports are the surprise hero: ₹1,255 crore in 9M FY26, contributing 22% of net sales. The company exports to 35+ countries across Latin America, Middle East, Southeast Asia, and Eastern Europe. Not sexy. But very profitable.
Margins are locked in the 20–24% OPM range. Distribution is the actual moat — 950+ distributors, 9,000+ field force, and presence across northern and western India (85% of cigarette sales). You can’t compete on cheaper smokes. You compete on availability. Godfrey has both.
Market Share~18%Indian Cigarettes
Volume Growth (9M)25%Domestic Cigarettes
Export Revenue₹1,255 Cr9M FY26
Marlboro Dependency Risk: The company pays royalties to PMI. If the exclusivity agreement gets renegotiated, or if Philip Morris decides to shift strategy, Godfrey’s profit could face headwinds. That said, PMI has been a stable partner for decades, and renegotiation is unlikely before 2030+.
💬 Question for you: Is a 25% volume growth story for cigarettes even viable in a world obsessed with ESG? Drop your thoughts in the comments.
04 — Financials Overview
Q3 FY26: The Numbers That Nobody Asked For
Result type: Quarterly Results | Q3 FY26 EPS: ₹22.01 | Annualised EPS (Q3×4): ₹88.04 | TTM EPS: ₹82.31
| Metric (₹ Cr) |
Q3 FY26
Dec 2025 |
Q3 FY25
Dec 2024 |
Q2 FY26
Sep 2025 |
YoY % |
QoQ % |
| Gross Sales Value | 4,737 | 3,956 | 3,974 | +19.7% | +19.2% |
| Net Sales (ex-Excise) | 1,829 | 1,589 | 1,289 | +15.1% | +41.9% |
| Operating Profit | 380 | 361 | 314 | +5.3% | +21.0% |
| OPM % | 21% | 23% | 24% | -200 bps | -300 bps |
| PAT | 343 | 316 | 305 | +8.2% | +12.6% |
| EPS (₹) | 22.01 | 20.25 | 19.56 | +8.7% | +12.5% |
P/E Reality Check: Q3 FY26 EPS annualised = ₹88.04. CMP ₹2,004 ÷ ₹88.04 = P/E of 22.75x. TTM P/E = ₹2,004 ÷ ₹82.31 = 24.36x. Either way, Godfrey trades at a premium to the industry median P/E of 20.6x. Margins compressed YoY due to higher tobacco input costs and a rising proportion of lower-margin unmanufactured tobacco exports in the mix. Volume growth is real. Margin expansion? Not happening soon.
05 — Valuation: Fair Value Range
What’s This Cigarette Company Actually Worth?
Join 10,000+ investors who read this every week.
